Physicochemical and pharmacokinetic characteristics of cationic liposomes

Pharmazie

Volumn 61, Issue 2, 2006, Pages 102-105

  Yeeprae, W ^a   Kawakami, S ^a   Suzuki, S ^a   Yamashita, F ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CHOLESTEROL; LIPOSOME; N [1 (2,3 DIOLEYLOXY)PROPYL] N,N,N TRIMETHYLAMMONIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CIRCULATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; FEMALE; GENE DELIVERY SYSTEM; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; ZETA POTENTIAL;

ANIMALS; AREA UNDER CURVE; CHEMISTRY, PHYSICAL; CHOLESTEROL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; FATTY ACIDS, MONOUNSATURATED; FEMALE; LIPOSOMES; MICE; MICE, INBRED ICR; PARTICLE SIZE; QUATERNARY AMMONIUM COMPOUNDS;

EID: 33644499525     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Dubey PK, Mishra V, Jain S, Mahor S, Vyas SP (2004) Liposomes modified with cyclic RGD peptide for tumor targeting. J Drug Target 12: 257-264.
2. Engel A, Chatterjee SK, Al-arifi A, Riemann D, Langner J, Nuhn P (2003) Influence of spacer length on interaction of mannosylated liposomes with human phagocytic cells. Pharm Res 20: 51-57.
3. Faneca H, Simoes S, Pedroso de Lima MC (2004) Association of albumin or protamine to lipoplexes: enhancement of transfection and resistance to serum. J Gene Med 6: 681-692.
4. Gerlowski LE and Jain RK (1983) Physiologically based pharmacokinetic modeling: Principles and applications. J Pharm Sci 72: 1103-1127.
5. Hattori Y, Kawakami S, Yamashita F, Hashida M (2000) Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting. J Control Release 69: 369-377.
6. Huang L, Li S (1997) Liposomal gene delivery: a complex package. Nat Biotechnol 15: 620-621.
7. Ishida E, Managit C, Kawakami S, Nishikawa M, Yamashita F, Hashida M (2004) Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice. Pharm Res 21: 932-939.
8. Ishida O, Maruyama K, Tanahashi H, Iwatsuru M, Sasaki K, Eriguchi M, Yanagie H (2001) Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharm Res. 18: 1042-1048.
9. Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M (2000a) In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm Res 17: 306-313.
10. Kawakami S, Wong J, Sato A, Hattori Y, Yamashita F, Hashida M (2000b) Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim Biophys Acta 1524: 258-265.
11. Kawakami S, Sato A, Nishikawa M, Yamashita F, Hashida M (2000c) Mannose receptor-mediated gene transfer into macrophage using novel mannosylated cationic liposomes. Gene Ther 7: 292-299.
12. Kawakami S, Munakata C, Fumoto S, Yamashita F, Hashida M (2001) Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs. J Pharm Sci 90: 105-113.
13. Kawakami S, Yamashita F, Nishida K, Nakamura J, Hashida M (2002) Glycosylated cationic liposomes for cell-selective gene delivery. Crit Rev Ther Drug Carrier Syst 19: 171-190.
14. Kawakami S, Hattori Y, Lu Y, Higuchi Y, Yamashita F, Hashida M (2004) Effect of cationic charge on receptor-mediated transfection using mannosylated cationic liposome/plasmid DNA complexes following the intravenous administration in mice. Pharmazie 59: 405-408.
15. Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268: 235-237.
16. Li S, Huang L (1997) In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 4: 891-900.
17. Litzinger DC, Brown JM, Wala I, Kaufman SA, Van GY, Farrell CL, Collins D (1996) Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim Biophys Acta 1281: 139-149.
18. Mady MM, Ghannam MM, Khalil WA, Repp R, Markus M, Rascher W, Muller R, Fahr A (2004) Efficient gene delivery with serum into human cancer cells using targeted anionic liposomes. J Drug Target 12: 11-18.
19. Mahato RI, Kawabata K, Takakura Y, Hashida M (1995) In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. J Drug Target 3: 149-157.
20. Mahato RI, Takakura Y, Hashida M (1997) Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations. Crit Rev Ther Drug Carrier Syst 14: 133-172.
21. Mahato RI, Anwer K, Tagliaferri F, Meaney C, Leonard P, Wadhwa MS, Logan M, French M, Rolland A (1998) Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum Gene Ther 9: 2083-2099.
22. Managit C, Kawakami S, Nishikawa M, Yamashita F, Hashida M (2003) Targeted and sustained drug delivery using PEGylated galactosylated liposomes. Int J Pharm 266: 77-84.
23. McLean JW, Fox EA, Baluk P, Bolton PB, Haskell A, Pearlman R, Thurston G, Umemoto EY, McDonald DM (1997) Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol 273: 387-404.
24. Pan XQ, Wang H, Lee RJ (2003) Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm Res 20: 417-422.
25. Papahadjopoulos D, Gabizon A (1990) Liposomes designed to avoid the reticuloendothelial system. Prog Clin Biol Res 343: 85-93.
26. Ruozi B, Forni F, Battini R, Vandelli MA (2003) Cationic liposomes for gene transfection. J Drug Target 11: 407-414.
27. Sakurai F, Nishioka T, Yamashita F, Takakura Y, Hashida M (2001) Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system. Eur J Pharm Biopharm 52: 165-172.
28. Schwiegelshohn B, Presley JF, Gorecki M, Vogel T, Carpentier YA, Maxfield FR, Deckelbaum RJ (1995) Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem 270: 1761-1769.
29. Song YK, Liu F, Chu S, Liu D (1997) Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther 8: 1585-1594.
30. Takakura Y, Fujita T, Hashida M, Sezaki H (1990) Disposition characteristics of macromolecules in tumor-bearing mice. Pharm Res 7: 339-346.
31. Tan Y, Liu F, Li Z, Li S, Huang L (2001) Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol Ther 3: 673-682.
32. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN (1997) Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 15: 647-652.
33. Teshima M, Kawakami S, Nishida K, Nakamura J, Sakaeda T, Terazono H, Kitahara T, Nakashima M, Sasaki H (2004) Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach. J Control Release 97: 211-218.
34. Yu W, Pirollo KF, Rait A, Yu B, Xiang LM, Huang WQ, Zhou Q, Ertem G, Chang EH. (2004) A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Ther 11: 1434-1440.
35. Zhang YF, Boado RJ, Pardridge WM (2003) Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes. Pharm Res 20: 1779-1185.
36. Zhu N, Liggitt D, Liu Y, Debs R (1993) Systemic gene expression after intravenous DNA delivery into adult mice. Science 261: 209-211.